Risk of tuberculosis in patients with cancer treated with immune checkpoint inhibitors: a nationwide observational study

BACKGROUND: While some recent studies have reported the development of tuberculosis (TB) in patients exposed to immune checkpoint inhibitors (ICIs), there is limited evidence to date. Therefore, we evaluated the risk of TB in patients with cancer exposed to ICIs using the National Health Insurance c...

Descripción completa

Detalles Bibliográficos
Autores principales: Bae, Seongman, Kim, Ye-Jee, Kim, Min-ju, Kim, Jwa Hoon, Yun, Sung-Cheol, Jung, Jiwon, Kim, Min Jae, Chong, Yong Pil, Kim, Sung-Han, Choi, Sang-Ho, Kim, Yang Soo, Lee, Sang-Oh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442094/
https://www.ncbi.nlm.nih.gov/pubmed/34521732
http://dx.doi.org/10.1136/jitc-2021-002960

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442094/
https://www.ncbi.nlm.nih.gov/pubmed/34521732
http://dx.doi.org/10.1136/jitc-2021-002960

Ejemplares similares